CX3CL1 and acute coronary syndrome: A recent study of patients with the acute coronary syndrome randomly assigned to colchicine (1.5 mg p.o.)[75] showed that colchicine treatment was associated with significantly lower transcoronary levels of chemokine ligand 2 (CCL2), CCL5, and C-X3-C motif chemokine ligand 1 (CX3CL1) (p < 0.05).